Multiple news organizations report that President Donald Trump plans to fire Food and Drug Administration Commissioner Marty Makary. Reporting from outlets including Bloomberg, NBC News, and MedPage Today says Trump has signed off on the firing plan, citing sources familiar with the matter. Other outlets describe the move as part of months of turmoil at the agency after Makary was installed as FDA commissioner in 2025.
The reporting characterizes Makary’s tenure as marked by high-profile decisions affecting public health and contentious clashes within the administration and with lawmakers. Sources cite disputes over areas such as abortion-related issues, vaping regulations, and drug approvals. The Guardian additionally highlights concerns about decisions involving communications and publications related to safety information for products and vaccines, and it mentions internal morale issues tied to layoffs and staffing changes.
While the accounts are broadly consistent that Trump is considering or has approved Makary’s removal, some reports also note that a final decision may not yet be fully confirmed. Collectively, the coverage describes a leadership dispute at a key federal regulator amid declining staff morale and plummeting public trust.
